CTLA4 and mesothelioma: CTLA-4 or CD152, is an immune system checkpoint receptor which downregulates immune system response by limiting co-stimulation, activation and subsequent proliferation of T cells through competition against the normal co-stimulatory signal and were first studied in mesothelioma [95].